Lynwood Capital Management Inc. - BRIACELL THERAPEUTICS CORP ownership

BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 2 filers reported holding BRIACELL THERAPEUTICS CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Lynwood Capital Management Inc. ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q3 2023$9,890,312
-2.7%
1,582,450
-0.1%
26.01%
+102.0%
Q2 2023$10,168,497
-10.8%
1,583,878
+3.5%
12.88%
+25.2%
Q1 2023$11,398,500
+170357.6%
1,530,0000.0%10.29%
+27.9%
Q4 2022$6,687
-99.9%
1,530,000
+27.7%
8.04%
+9.4%
Q3 2022$6,733,000
+89.7%
1,198,000
+94.8%
7.35%
+85.5%
Q2 2022$3,549,000
-53.3%
615,000
-18.0%
3.96%
-51.4%
Q1 2022$7,605,000
+17.0%
750,000
-4.5%
8.16%
+31.2%
Q4 2021$6,500,000785,0006.22%
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q4 2023
NameSharesValueWeighting ↓
Lynwood Capital Management Inc. 1,198,000$6,733,0007.35%
K.J. Harrison & Partners Inc 479,838$2,748,0000.97%
SABBY MANAGEMENT, LLC 94,005$528,0000.67%
Redmond Asset Management, LLC 137,689$774,0000.29%
Concord Wealth Partners 17,775$100,0000.03%
Virtu Financial LLC 48,347$272,0000.02%
Caption Management, LLC 177,000$996,0000.01%
WASATCH ADVISORS LP 353,744$1,988,0000.01%
Summit Trail Advisors, LLC 35,000$197,0000.01%
BLUEFIN CAPITAL MANAGEMENT, LLC 17,546$99,0000.01%
View complete list of BRIACELL THERAPEUTICS CORP shareholders